Lead Hematology & Ophthalmology Medical Affairs (MA) analytics teams for exploratory analysis, publications, and health technology assessment (HTA) using clinical data & real-world data (RWD). Oversee Phase IV and registry trials programming & analytics activities by in-house programmers and remotely by Functional Service Providers (FSPs) and Contract Research Organizations (CROs). Organize statistical & data findings, materialize recommendations, and communicate results to internal & external partners for decision making. Represent my department in strategic planning and cross-functional caucuses.Develop and implement programming processes, reporting standards, and best practices. Propel innovation by identifying and implementing new technologies, macros / reusable programming blocks, and efficient workflow.

Statistics, exploratory analysis, data derivation, and publication for clinical data, real world data (RWD), and real world evidence (RWE). Liaison of outsource partners and CROs. Built analysis standards, house macros, SAS and R algorithms.

Directed statistics and programming teams supporting Galafold product launch. Managed internal & external resources for publications, medical advisory boards (MABs), ad-hoc statistical analysis, and data integration (ISE+ ISS). Developed Real World data (RWD) disease registry. Conduct clinical trials (Ph IV) & data explorations. Provided crucial opinions, interpretation, & expertise for business decisions. Served on Institutional Review Board (IRB) for reviewing internal protocols and investigator-initiated studies (IIS). Researched and congregated various sources of Real World Evidence (RWE). Supported new drug application (NDA): Statistical Analysis Plans (SAPs) and CDISC data (ADaM/SDTM). Collaborated with Key Opinion Leaders (KOLs) and Medical Science Liaisons (MSLs) on special research initiatives & projects.

Managed US clinical statistics group of internal consultants, functional service providers (FSPs), & contract research organizations (CROs). Designed statistical analysis plans (SAPs) & protocols for Over-The-Counter (OTC) cosmeceutical products, efficacy & safety claims, and digital health wearable devices. Explored machine learning, simulation, and other new data science technology to expedite product development cycles. Advanced best practices, standards, & analysis tools across research hubs in Americas, Europe, and Asia. Provided statistics training and data consultancy for 500+ employees on US campuses.

Conducted marketing research and position analysis for health and nutrition products launches. Design & conduct surveys and focus group studies and analyze the results. Identify potential research collaborations & publications between the sponsor and universities.

Provided guidance and assistance to senior officer team to for the best use of their volunteer time and human capital. Strategized expansions to new geographical areas and new markets such as trade associations, labor unions, colleges, LGBT groups, local businesses, and communities.Mediated resolutions if conflicts arise.

Conducted medical safety, malpractice, health economics and outcome research (HEOR), risk management, and physician/patient surveys on electronic medical/health records (EMR / EHR), custom-build SQL/Access databases, and real world data & evidence (RWE) including insurance claims, registries, and public data sources. Communicated statistical information & insights via data visualization, customized spreadsheets & reports to senior executives, investigators, and risk management staff. Coordinate publications and presentations. Provided statistical consulting services and education to internal staff.

(Formerly Forest Laboratories)Analysis & reporting lead for a novel compound, responsible for NDA / regulatory submission resource distribution, conflict resolutions, crisis management, and internal / external communication with an overseas company. Programmed SAS codes for derived data, pharmacokinetic (PK) / pharmacodynamic (PD), Health Economics and Outcome Research (HEOR), Phase II & III studies tables / graphs / listings. Assessed qualities of analysis results and databases of potential acquisition partners for the business development team. Oversaw service providers’ deliverable and timeline. Statistical Plan (SAP) review.

As District Governor / CEO of District 83, I have supervised and provided direct guidance and training to a core team of 26 area governors, 5 division governors, 5 senior officers, and 2 conference chairs. My team finished with bronze prize in the Northeast US. My day-to-day duties included volunteer supervision, strategic planning, officer training, conflict management, budgeting, and Public Relations.This position may be the most challenging 'job'​ I have ever hold. I had the honor and pleasure of working with more than 3500 talented leaders and communicators in Metro NJ and New York. I operated like a CEO responsible for the success of all my members with very limited budget.

Designated as contact person for ad-hoc and exploratory analysis for senior management . Generated SAS statistical summary tables and patient data listings for clinical trials Phase 2 & 3. Reviewed statistical analysis plans, annotated CRFs, and database structure. Provided feedback to clinical management team to improve the design and execution.